Quipt Home Medical (NASDAQ:QIPT - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.09), Zacks reports. Quipt Home Medical had a negative return on equity of 6.70% and a negative net margin of 2.90%. The company had revenue of $57.40 million during the quarter, compared to analysts' expectations of $88.29 million.
Quipt Home Medical Price Performance
NASDAQ QIPT traded down $0.10 during mid-day trading on Friday, hitting $1.41. The stock had a trading volume of 1,131,931 shares, compared to its average volume of 194,427. The firm's 50 day moving average is $2.12 and its 200 day moving average is $2.54. Quipt Home Medical has a twelve month low of $1.35 and a twelve month high of $4.07. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.22 and a quick ratio of 0.87. The stock has a market capitalization of $60.76 million, a price-to-earnings ratio of -8.29 and a beta of 0.65.
Analysts Set New Price Targets
Several research firms have commented on QIPT. Canaccord Genuity Group restated a "hold" rating and issued a $1.70 price objective (down previously from $4.00) on shares of Quipt Home Medical in a research report on Tuesday. Benchmark restated a "buy" rating and issued a $4.00 price objective (down previously from $6.00) on shares of Quipt Home Medical in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, two have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $4.43.
Get Our Latest Analysis on QIPT
Quipt Home Medical Company Profile
(
Get Free Report)
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
See Also

Before you consider Quipt Home Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.
While Quipt Home Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.